MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-389

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    Really like and respect you Dolce, but I question whether your passion and enthusiasm is serving you well in this stock. If the low back pain trial dissapoints then SI's claims are likely to completely unravel as critics claim the emperor has no clothes. I worry investors won't have taken the precaution of limiting their exposure according to the heightened risks now apparent.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.